Prothena Corp plc (PRTA) - NASDAQ
From other sites
Company Description
Prothena Corp. Plc is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion. It also focuses on therapeutic monoclonal antibodies... More
Sector: Healthcare
Industry: Drug Delivery & Accessories
Country: Ireland